Search
for
Sort by
Research 91–120 of 180
- An Updated in the Management of Alopecia Areata
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Efficacy and safety of baricitinib in patients with refractory alopecia areata
- When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- A Pilot Randomized Controlled Trial Comparing the Efficacy and Safety of Oral Tofacitinib Versus Methotrexate In Moderate-to-Severe Alopecia Areata
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Race and Ethnicity Sub-Groups of Alopecia Areata Patients have Differing Clinical Characteristics: TARGET-DERM AA
- Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Estimation of health utility values for alopecia areata
- Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
- Dupilumab and Alopecia Areata: A Possible Combined or Disturbance Therapy? A Review of the Literature
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Retrospective Analysis of Oral Tofacitinib Treatment for Alopecia Areata at a Tertiary Care Hospital in Saudi Arabia
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata
- Patient Validation of Estimation of Health Utility Values in Alopecia Areata
- Alopecia Universalis Hair Regrowth with Hormones
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Case Report: Successful treatment of pediatric alopecia universalis with ritlecitinib after failure of baricitinib
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Evidence for the off-label use of tofacitinib in alopecia areata
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective